Skip to Content

Lubiprostone Pregnancy and Breastfeeding Warnings

Lubiprostone is also known as: Amitiza

Lubiprostone Pregnancy Warnings

Some animal studies revealed a dose-dependent increase in fetal loss but no increase in structural malformations. Other animal data showed increased incidences of early resorptions and soft tissue malformations, but those effects were likely secondary to maternal toxicity. Animal studies also demonstrated significant reduction of implantation sites and live embryos, but no effect on male and female fertility and reproductive function at oral doses up to 1000 mcg/kg/day. There are no controlled data in human pregnancy. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

UK: Use is not recommended during pregnancy and in women of childbearing potential not using contraception. US: Potential benefit should outweigh possible risk to the fetus. US FDA pregnancy category: C

See references

Lubiprostone Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: No Comments: -A risk to the nursing infant cannot be excluded. -Breastfed infants should be monitored for diarrhea because this drug increases intestinal fluid secretion and motility.

See references

References for pregnancy information

  1. "Product Information. Amitiza (lubiprostone)." Sucampo Pharmaceuticals Inc, Bethesda, MD.

References for breastfeeding information

  1. "Product Information. Amitiza (lubiprostone)." Sucampo Pharmaceuticals Inc, Bethesda, MD.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.